Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Analyst Recommendations on PFIZER, INC.
06/17PFIZER  : Price Target From RBC Lifted to $44 From $43 as Firm Raises Vaccine Re..
MT
06/15ANALYST RECOMMENDATIONS : Anglo American, Pfizer, Rolls-Royce, Nike, Oatly...
06/15PFIZER INC  : Berenberg reiterates its Neutral rating
MD
05/24TODAY'S ANALYST RECOMMENDATIONS : Applied Materials, easyJet, Pfizer, Ralph Laur..
05/24PFIZER INC  : Goldman Sachs reiterates its Neutral rating
MD
05/24PFIZER INC  : JP Morgan reiterates its Neutral rating
MD
05/13PFIZER INC  : Gets a Neutral rating from Goldman Sachs
MD
05/10PFIZER  : Berenberg Bank Adjusts Pfizer PT to $43 From $38 on Significant Increa..
MT
05/10PFIZER  : Morgan Stanley Adjusts Pfizer's Price Target to $42 From $38, Keeps Eq..
MT
05/06PFIZER  : Mizuho Downgrades Pfizer to Neutral Rating From Buy, Price Target is $..
MT
05/05PFIZER  : Goldman Sachs Adjusts Pfizer's Price Target to $45.11 From $43, Mainta..
MT
05/05PFIZER  : JPMorgan Adjusts Pfizer's Price Target to $40 From $34.13, Maintains N..
MT
05/05PFIZER  : SVB Leerink Adjusts Price Target on Pfizer to $43 From $39, Maintains ..
MT
05/05PFIZER  : Barclays Adjusts Pfizer's Price Target to $40 From $37, Keeps Equal-We..
MT
05/05PFIZER  : RBC Capital Adjusts Pfizer's Price Target to $43 From $42, Keeps Secto..
MT
05/05PFIZER INC  : Gets a Neutral rating from Barclays
MD
03/31PFIZER INC  : Goldman Sachs sticks Neutral
MD
03/26PFIZER  : SVB Leerink Adjusts Pfizer PT to $39 From $40, Maintains Market Perfor..
MT
03/23PFIZER  : Berenberg Bank Adjusts Pfizer PT to $38 From $40, Maintains Hold Ratin..
MT
03/23PFIZER INC  : Gets a Neutral rating from Berenberg
MD
03/12PFIZER INC  : Goldman Sachs sticks Neutral
MD
03/09PFIZER INC  : Goldman Sachs remains Neutral
MD
02/04PFIZER  : DZ Bank Upgrades Pfizer to Buy From Hold; Price Target is $41
MT
02/03CORRECTION : --Analyst Actions: Goldman Sachs Adjusts Price Target for UPS to $2..
MT
02/03CORRECTION : --Analyst Actions: Deutsche Bank Adjusts Price Target for UPS to $1..
MT
02/03PFIZER  : Goldman Sachs Adjusts Price Target for Pfizer to $208 From $200, Maint..
MT
02/03PFIZER  : Deutsche Bank Adjusts Price Target for Pfizer to $185 From $201, Maint..
MT
02/03PFIZER  : Mizuho Adjusts Pfizer's Price Target to $42 From $44, Keeps Buy Rating
MT
02/03PFIZER  : SVB Leerink Adjusts Price Target on Pfizer to $40 From $41.71, Maintai..
MT
02/03PFIZER INC  : DZ Bank raises its recommendation to Buy
MD
02/02PFIZER INC  : JP Morgan sticks Neutral
MD
02/01PFIZER  : RBC Capital Reiterates Pfizer Sector Perform Rating and $42 PT, Lookin..
MT
01/29PFIZER  : Morgan Stanley Adjusts Pfizer's Price Target to $38 From $40, Keeps Eq..
MT
01/21PFIZER INC  : Goldman Sachs reiterates its Neutral rating
MD
01/08PFIZER INC  : Goldman Sachs gives a Neutral rating
MD
2020PFIZER INC  : RBC remains Neutral
MD
2020PFIZER  : RBC Capital Downgrades Pfizer to Sector Perform From Outperform, Adjus..
MT
2020PFIZER INC  : Goldman Sachs gives a Neutral rating
MD
2020PFIZER INC  : Goldman Sachs remains Neutral
MD
2020PFIZER  : FDA Panel Endorses Covid-19 Vaccine -- 7th Update
DJ
2020PFIZER  : FDA Panel Endorses Covid-19 Vaccine -- 6th Update
DJ
2020PFIZER  : FDA Panel Endorses Covid-19 Vaccine -- 5th Update
DJ
2020PFIZER  : FDA Advisory Panel Endorses Pfizer-BioNTech Covid-19 Vaccine -- 3rd Up..
DJ
2020WALL STREET WEEK AHEAD : After blazing energy rally, investors check the fuel ga..
RE
2020PFIZER  : Barclays Adjusts Pfizer PT to $37 From $33.18, Maintains Equal Weight ..
MT
2020German bond yields dip before U.S. jobs data, but set for biggest weekly rise..
RE
2020Pfizer and BioNTech's Covid-19 Vaccine Wins U.K. Authorization -- 7th Update
DJ
2020PFIZER INC  : Barclays sticks Neutral
MD
2020UK approves Pfizer-BioNTech COVID-19 vaccine in world first
RE
2020PFIZER INC  : RBC gives a Buy rating
MD
2020PFIZER INC  : Gets a Neutral rating from Goldman Sachs
MD
2020AstraZeneca Gears Up to Vaccinate the World Against Covid-19
DJ
2020AstraZeneca, Oxford Covid-19 Vaccine Up to 90% Effective in Late-Stage Trials..
DJ
2020Rand jumps despite ratings downgrade, EM stocks rally on vaccine hopes
RE
2020PFIZER, GILEAD, ROSS : What to Watch When the Stock Market Opens Today
DJ
2020PFIZER  : Goldman Resumes Pfizer at Neutral With $40 Price Target
MT
2020MACY'S, NVIDIA, SIMON PROPERTY GROUP : What to Watch When the Stock Market Opens..
DJ
2020NVIDIA, SIMON PROPERTY GROUP, BNY ME : What to Watch When the Stock Market Opens..
DJ
2020Pfizer Says Covid Vaccine Is 95% Effective in Final Data, Will Seek Authoriza..
DJ
2020Pfizer's Covid-19 Vaccine 95% Effective in Final Results, Company to Seek App..
DJ
2020Rate cut bets melt as vaccines boost economy hopes
RE
2020Aramco Plans U.S. Dollar Bond to Plug Funding Gap -- Update
DJ
2020PFIZER  : Bernstein Reinstates Pfizer at Market Perform with $42 Price Target
MT
2020Arcturus expects its COVID-19 vaccine to be ready by Q1 2021
RE
2020PFIZER  : BioNTech Shares Hit 52-Week Highs on Covid-19 Vaccine Candidate News
DJ
2020PFIZER INC  : JP Morgan reaffirms its Neutral rating
MD
2020PFIZER INC  : Barclays remains Neutral
MD
2020PFIZER  : BioNTech Shares Rise After Positive News for Covid-19 Vaccine Candidat..
DJ
2020PFIZER INC  : RBC reiterates its Buy rating
MD
2020PFIZER INC  : Buy rating from RBC
MD
2020Exxon's Departure From Dow Highlights Market's Retreat From Energy Bets
DJ
2020Top FDA official says would resign if agency rubber-stamps an unproven COVID-..
RE
2020Top FDA official says would resign if agency rubber-stamps an unproven COVID-..
RE
2020U.S. FDA rejects BioMarin hemophilia A gene therapy, shares dive
RE
2020Moderna shares rise 11% on $1.5 billion U.S. contract for COVID-19 vaccine
RE
1  2Next
Official Publications
04/12Report 
04/02Report 
03/31Report 
03/25Report 
03/15Report 
02/27Report 
Upcoming event on PFIZER, INC.